BioSpace News Archive

Drug Development

All Primary and Secondary Outcome Targets Met in Mallinckrodt’s Phase 4 Acthar® Gel (Repository Corticotropin Injection) Rheumatoid Arthritis (RA) Clinical Trial (n=259) with Data Presented at the European Congress of Rheumatology 2019 (EULAR)

Study met primary outcome measure; 63 percent of patients with persistently active RA achieved low disease activity (LDA) as assessed by DAS28-ESR¹ at Week 12

June 13, 2019
·
15 min read
Deals

Provention Bio Announces Termination of Public Offering of Common Stock

Provention Bio, Inc. announced that it has terminated the public offering of common stock previously announced on June 10, 2019.

June 13, 2019
·
2 min read
Pharm Country

Altitude Establishes European investment strategy with $2.4mm equity investment in EMMAC Life Sciences Limited

UK-headquartered EMMAC is a European medical cannabis company, combining the latest science and research with cutting-edge cultivation, extraction, and production.

June 13, 2019
·
3 min read
Biotech Beach

Arena Pharmaceuticals to Present at JMP Securities Life Sciences Conference on June 19

JMP Securities Life Sciences Conference on Wednesday, June 19, 2019, at 1:30 PM EDT. The conference will take place June 19-20, 2019, in New York City.

June 13, 2019
·
3 min read
Pharm Country

TELA Bio® to Participate in JMP Securities Life Sciences Conference

JMP Securities Life Sciences Conference to be held June 19-20, 2019 at the St. Regis in New York City.

June 13, 2019
·
1 min read
Business

Righttime Medical Care Opens 19th Location in Towson, Maryland

Maryland-based urgent care company Righttime Medical Care has opened its newest Care Center in Towson at 4825 York Road.

June 13, 2019
·
2 min read